Results 261 to 270 of about 73,607 (303)

Aging changes the mechanism that underlies JAK2 modulation of neutrophil function. [PDF]

open access: yesJ Immunol
Feldmann JW   +6 more
europepmc   +1 more source

Polycythemia Vera with Incidental Large Aortic Aneurysm and Giant Cell Arteritis: Case Report. [PDF]

open access: yesClin Med Insights Case Rep
Obaid K   +8 more
europepmc   +1 more source

Late Onset Telomere Biology Disorder Presenting With Pancytopenia, Immune Dysregulation, Interstitial Lung Disease and Alopecia

open access: yes
American Journal of Hematology, Volume 101, Issue 6, Page 1196-1200, June 2026.
Bo A. Wan   +7 more
wiley   +1 more source

JAK2, the JAK2 V617F mutant and cytokine receptors

open access: yesPathologie Biologie, 2007
Recently, a unique recurrent somatic mutation was identified as a major molecular event in polycythemia vera, essential thrombocythemia and idiopathic myelofibrosis. Expression of this mutant in cytokine-dependent hematopoietic cell lines induces autonomous growth. This effect is enhanced by overexpression of cytokine receptors, and can be inhibited by
J, Staerk   +7 more
openaire   +3 more sources

JAK2-mediated Intracellular Signaling

Current Molecular Medicine, 2021
Janus kinase-2 (JAK2) is a non-receptor tyrosine kinase that serves key roles as the intracellular signaling effector of the cytokine receptor, such as mediating effects of leptin, erythropoietin, interferon, and growth hormone. A lot of molecular underlying mechanisms of JAK2 participation are known, however, additional signaling mechanisms of its ...
Mentor Sopjani   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy